blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3888664

EP3888664 - COMPOSITION, FOR PREVENTING, RELIEVING OR TREATING CARTILAGE-RELATED DISEASES OR SYMPTOMS, COMPRISING HAPLN1 [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  06.04.2023
Database last updated on 26.07.2024
FormerRequest for examination was made
Status updated on  03.09.2021
FormerThe international publication has been made
Status updated on  04.09.2020
Most recent event   Tooltip19.02.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
HAPLNSCIENCE INC.
B-1001ho, 10F
660, Daewangpangyo-ro
Bundang-gu
Seongnam-si
Gyeonggi-do 13494 / KR
[2021/40]
Inventor(s)01 / KIM, Dae Kyong
90-13, Dongmak-ro 245beon-gil, Bundang-gu
Seongnam-si Gyeonggi-do 13547 / KR
02 / JANG, Ji Min
421ho, 1dong, 45, Yeouidaebang-ro, Yeongdeungpo-
gu
Seoul 07435 / KR
 [2021/40]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2021/40]
Application number, filing date19917174.528.02.2019
[2021/40]
WO2019KR02418
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020175721
Date:03.09.2020
Language:KO
[2020/36]
Type: A1 Application with search report 
No.:EP3888664
Date:06.10.2021
Language:EN
[2021/40]
Search report(s)International search report - published on:KR03.09.2020
(Supplementary) European search report - dispatched on:EP12.11.2021
ClassificationIPC:A61K31/728, A61K38/14, A23L33/10, A61P19/02, A61P19/04, A61P19/08
[2021/50]
CPC:
A61P19/02 (EP,US); A61K38/1709 (US); A23K20/147 (US);
A23L33/10 (EP); A23L33/17 (US); A61K31/728 (EP);
A61K38/17 (EP); A61P19/00 (EP); A61P19/04 (EP,US);
A61P19/08 (EP,US) (-)
C-Set:
A61K31/728, A61K2300/00 (EP)
Former IPC [2021/40]A61K31/728, A61K38/14, A23L33/10
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/40]
TitleGerman:ZUSAMMENSETZUNG ZUR VORBEUGUNG, LINDERUNG ODER BEHANDLUNG VON KRANKHEITEN ODER SYMPTOMEN IM ZUSAMMENHANG MIT HAPLN1[2021/40]
English:COMPOSITION, FOR PREVENTING, RELIEVING OR TREATING CARTILAGE-RELATED DISEASES OR SYMPTOMS, COMPRISING HAPLN1[2021/40]
French:COMPOSITION POUR PRÉVENIR, SOULAGER OU TRAITER DES MALADIES OU DES SYMPTÔMES LIÉS AU CARTILAGE, COMPRENANT LA HAPLN1[2021/40]
Entry into regional phase15.06.2021Translation filed 
15.06.2021National basic fee paid 
15.06.2021Search fee paid 
15.06.2021Designation fee(s) paid 
15.06.2021Examination fee paid 
Examination procedure15.06.2021Examination requested  [2021/40]
29.03.2022Amendment by applicant (claims and/or description)
05.04.2023Despatch of a communication from the examining division (Time limit: M04)
12.05.2023Reply to a communication from the examining division
Fees paidRenewal fee
15.06.2021Renewal fee patent year 03
23.02.2022Renewal fee patent year 04
21.02.2023Renewal fee patent year 05
19.02.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]EP3677269  (HAPLNSCIENCE INC [KR]) [E] 1,2,5-9 * claims 1-6; paragraphs 4, 5, 13; examples 1 and 3 *;
 [Y]  - NAOMI MOROZUMI ET AL, "ASB20123: A novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism", PLOS ONE, (20190222), vol. 14, no. 2, doi:10.1371/journal.pone.0212680, page e0212680, XP055750836 [Y] 3,4 * abstract *

DOI:   http://dx.doi.org/10.1371/journal.pone.0212680
 [Y]  - WATANABE H ET AL, "MICE LACKING LINK PROTEIN DEVELOP DWARFISM AND CRANIOFACIAL ABNORMALITIES", NATURE GENETICS, NATURE PUBLISHING GROUP US, NEW YORK, (19990201), vol. 21, no. 2, doi:10.1038/6016, ISSN 1061-4036, pages 225 - 229, XP001147148 [Y] 3,4 * abstract *

DOI:   http://dx.doi.org/10.1038/6016
International search[A]US2014178988  (WEST MICHAEL [US], et al) [A] 1-9;
 [A]WO2014130411  (UNIV EMORY [US], et al) [A] 1-9;
 [X]US2016220699  (O'HEERON PETE [US]) [X] 1-9;
 [X]WO2017123951  (SPINACYTE LLC [US]) [X] 1-9;
 [E]KR20190024727  (UNIV CHUNG ANG IND ACAD COOP FOUND [KR])[E] 1-9;
 [A]  - URANO et al., "Single-nucleotide polymorphism in the hyaluronan and proteoglycan link protein 1 (HAPLN1) gene is associated with spinal osteophyte formation and disc degeneration in Japanese women", European Spine Journal, (20110000), vol. 20, doi:10.1007/s00586-010-1598-0, pages 572 - 577, XP019891028 [A] 1-9

DOI:   http://dx.doi.org/10.1007/s00586-010-1598-0
by applicantUS2016220699
 WO2017123951
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.